ClinicalTrials.Veeva

Menu

Diagnostic Utility of Pleural Fluid MAGE Assay in Patients With Pleural Effusion From Primary Lung Cancer

Samsung Medical Center logo

Samsung Medical Center

Status

Completed

Conditions

Unilatral Pleural Effusion

Treatments

Procedure: pleural fluid tapping

Study type

Interventional

Funder types

Other

Identifiers

NCT01179685
2008-08-043

Details and patient eligibility

About

Melanoma antigen (MAGE) gene is known to be expressed in tumor cells, testis and placenta. The purpose of this prospective study was to investigate the sensitivity, specificity and accuracy of pleural fluid MAGE gene expression, tumor marker and cytology in the diagnosis of malignant pleural effusion.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • unilateral pleural effusion on chest radiography

Exclusion criteria

  • body temperature > 38.3ºC and peripheral blood leukocytosis (>12,000/μl)

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems